Considerations for the US health-system pharmacist in a world of biosimilars
As numerous biosimilar products are forecast to enter the US market in the coming years, health-system pharmacists will be faced with novel challenges while incorporating them into clinical practice. The current regulatory approval framework and guidance from the US Food and Drug Administration do n...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
BioExcel Publishing Ltd,
2020-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|